HOOKIPA Pharma Inc. 3 SEC Filings

Filed On	Filing
24 Jul 2024	Form 3: Cassidy Sean A, Director No securities owned
11 Apr 2024	Form 3: Winderlich Mark, Chief Development Officer No securities owned
22 Dec 2023	Form 3: Gilead SCIENCES, Inc., 10% owner Holds 18,759,465 shares of Common Stock
18 Apr 2023	Form 3: Schlienger Katia, Chief Medical Officer Holds 1,300 shares of Common Stock
18 Apr 2023	Form 3: Peters Malte, Director No securities owned
04 Apr 2023	Form 3: Coelho Mary Theresa, Director No securities owned
20 Apr 2022	Form 3: Reilly Timothy P., Director No securities owned
17 Feb 2022	Form 3: Gilead Sciences Inc, 10% owner Holds 3,759,465 shares of Common Stock
22 Mar 2021	Form 3: Baker Christine D., Chief Business Officer Holds 2,500 shares of Common Stock
23 Oct 2020	Form 3: Soria Jean-Charles, Director No securities owned
19 Nov 2019	Form 3: Necina Roman, Chief Technology Officer No securities owned
18 Apr 2019	Form 3: Baker Bros. Advisors Lp, 10% owner and 3 others
17 Apr 2019	Form 3: Redmile Group, Llc, 10% owner and 1 other
17 Apr 2019	Form 3: van Deventer Sander, Director No securities owned
17 Apr 2019	Form 3: Seghezzi Graziano, Director No securities owned
17 Apr 2019	Form 3: Sofinnova Capital Vi Fcpr, 10% owner and 1 other Holds 82,456 shares of Common Stock
17 Apr 2019	Form 3: Kaufman David Ross, Director No securities owned
17 Apr 2019	Form 3: Aldag Jorn, Director
17 Apr 2019	Form 3: Matushansky Igor, Chief Medical Officer Holds 28,583 shares of Common Stock
17 Apr 2019	Form 3: Kandera Reinhard, Director

Comments